Indian Drug Manufacturers Association (IDMA), which is supporting Pharmexcil’s iPHEX 2013 inaugural event, is organising a seminar on ‘India: Destination of Choice for Quality Medicines’ at iPHEX 2013 on April 24 and 25 in Mumbai. The event will be attracting the entire Indian pharma industry and will have participation of about 400 foreign buyers and regulators from many countries.

On Day 1, a panel discussion on ‘Hassle Free Exports’ based on the seminar theme will be held with industry stalwarts such as Smitesh Shah, CMD, Calyx Chemicals & Pharmaceuticals Ltd, Dr Milind Joshi, president, Global Regulatory Management, JB Chemicals & Pharmaceuticals Ltd., Dr Ajit Dangi, president & CEO, Danssen Consulting, Dr Raja Smarta, managing director, Interlink Marketing Consulting and other experts as panelists Utkarsh Palnitkar, Partner (Head of Transactions and Restructuring), KPMG India will moderate the panel discussion.

The seminar on the second day will have presentations on ‘Pharma Branding’ by Sudarshan Jain, MD, Healthcare Solutions, Abbott Healthcare, ‘Success Stories of Indian companies in Exports’ by Sriram Shrinivasan, partner, Life Sciences, Accenture India, and others on relevant topics such as 'Biosimilars – Look before you Leap', 'Financing Pharma Exports' etc.

An interactive session with overseas regulators is also scheduled on the second day, wherein they will be requested to highlight their regulatory framework and how they can help in easing import of medicines from India.

This interactive seminar will help delegates to inculcate skills to enable them and their teams to improve their abilities, and build ‘Made in India’ pharmaceutical brands for global markets.